Every Form 4 that Tenet Healthcare Corporation New (THC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow THC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full THC filings page.
TENET HEALTHCARE CORP (THC) director Nadja West reported selling 1,152 shares of common stock on September 2, 2026 in a sale described as an open market or private transaction at $258.80 per share. After this transaction, she reported directly holding 23,653 shares of Tenet Healthcare common stock. No Rule 10b5-1 trading plan is reported.
TENET HEALTHCARE CORP (THC) executive Lisa Y. Foo, EVP and Chief Operating Officer, reported selling 24,000 shares of common stock on August 31, 2026, in an open-market transaction at a weighted average price of $266.32 per share. After these sales, she directly holds 8,053 shares of Tenet Healthcare common stock. The shares were sold in multiple trades at prices ranging from $266.02 to $266.95 per share.
TENET HEALTHCARE CORP (THC) director Cecil D. Haney reported a charitable transfer of company stock. On 2026-08-28, he made a bona fide gift of 150 shares of Tenet Healthcare common stock, with no sale proceeds received, to a charitable donor advised fund. Following this transaction, he directly holds 12,403 shares of Tenet Healthcare common stock.
TENET HEALTHCARE CORP (THC) reported that director Cecil D. Haney sold 1,300 shares of common stock on 2026-08-24. The sale was reported as a non-derivative transaction in an open market or private transaction at a price of $278.03 per share, leaving him with 12,553 directly held shares. The Rule 10b5-1 checkbox was left unchecked, and no footnotes were provided.
TENET HEALTHCARE CORP (THC) reported that CEO and director Saumya Sutaria sold a total of 100,000 shares of common stock in open-market or private transactions on August 24–25, 2026. The sales occurred at weighted-average prices with trade ranges between $272.65 and $279.14 per share, and detailed price breakdowns are available upon request.
Tenet Healthcare Corp director Tammy Romo reported two open-market sales of Common Stock. On 2026-08-07, she sold 2,500 shares at $260.83 per share, and on 2026-08-06 she sold 4,922 shares at $264.15 per share, totaling 7,422 shares sold. Both positions were reported as direct ownership; post-transaction holdings were not stated.
Tenet Healthcare Corp director Roy Blunt reported selling 600 shares of Common Stock on 2026-08-05 at a weighted average price of $262.68 per share, executed in multiple trades between $262.52 and $262.70. After this sale, he directly holds 4,589 shares.
Tenet Healthcare Corp executive vice president and chief operating officer Lisa Y. Foo reported selling 10,000 shares of Common Stock on 2026-07-29 in an open-market transaction at a weighted average price of $258.03 per share, based on multiple trades between $257.97 and $258.43.
After this sale, Foo directly holds 32,053 shares of Tenet Healthcare Common Stock. The Rule 10b5-1 trading-plan checkbox was not marked, and the insider has undertaken to provide detailed trade-by-trade pricing information upon request to the company, its security holders, or SEC staff.
Tenet Healthcare Corp director Christopher S. Lynch reported selling 3,837 shares of Common Stock on July 27, 2026, in an open-market or private transaction at $243.44 per share. Following the sale, he directly owns 9,568 shares. The Rule 10b5-1 trading plan checkbox was not marked.
Tenet Healthcare Corp executive Paola M. Arbour, EVP and Chief Information Officer, sold 10,878 shares of common stock on July 27, 2026 in a transaction reported as a sale in open market or private transactions at a weighted average price of $243.90 per share, with individual prices ranging from $243.82 to $244.08. Following this sale, she directly holds 18,413 shares of Tenet Healthcare common stock. The transaction was not marked as made under a Rule 10b5-1 trading plan.
Tenet Healthcare Corp director James L. Bierman reported selling 5,000 shares of Common Stock on July 27, 2026, in an open-market or private transaction at a weighted average price of $244.96 per share. The sales occurred between $244.95 and $245.29 and left him with 31,604 directly owned shares.
Tenet Healthcare director J. Robert Kerrey reported open-market sales of company common stock. On May 28, 2026, he sold a total of 5,638 shares in multiple transactions at weighted average prices within ranges from $172.63 to $178.08 per share, as detailed in the footnotes. After these sales, he directly owns 16,804 shares of Tenet Healthcare common stock.
Agarwala Vineeta reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare Corp director Vineeta Agarwala received a grant of 1,188 restricted stock units. These 2026 May Restricted Stock Units were awarded at no cost and are each economically equivalent to one share of Tenet’s common stock.
The units vest on the first anniversary of the grant date, aligning Agarwala’s compensation with the company’s future performance. After this grant, she holds 1,188 restricted stock units directly. She may elect to receive up to 37% of the vested units in cash instead of shares.
Blunt Roy reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare director Roy Blunt received a grant of 1,188 restricted stock units as compensation. These 2026 May Restricted Stock Units were awarded at a price of $0.00 per unit and are economically equivalent to 1,188 shares of Tenet common stock.
The units vest on the first anniversary of the grant date, so they are scheduled to vest on May 27, 2027, if service-based conditions are met. After this grant, Blunt holds 1,188 restricted stock units directly. He may elect to receive up to 37% of these vested units in cash instead of shares, which gives some flexibility in how the award is settled.
MARK RICHARD J reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare director Richard J. Mark received a grant of 1,188 restricted stock units. The 2026 May RSUs were awarded at no cost and are equivalent to 1,188 shares of common stock. They vest on the first anniversary of the grant, and up to 37% may be settled in cash instead of shares.
TENET HEALTHCARE CORP director Nadja West reported mixed insider activity. She completed an open-market sale of 3,000 shares of Common Stock at $177.35 per share and now directly holds 24,805 shares. She was also granted 1,188 restricted stock units that vest on the first anniversary of the grant, each equivalent to one common share, with an option to receive up to 37% of these units in cash.
Tenet Healthcare director Richard W. Fisher received a new equity award in the form of restricted stock units. On May 27, 2026, he was granted 1,188 2026 May Restricted Stock Units, each economically equivalent to one share of Tenet’s common stock.
The award was granted under the company’s Stock Incentive Plan at no exercise price and will vest on the first anniversary of the grant date. After this grant, Fisher holds 1,188 restricted stock units directly, and he may elect to receive up to 37% of these units in cash instead of shares at settlement.
HANEY CECIL D reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare director Cecil D. Haney received a grant of 1,188 restricted stock units as equity compensation. The units were granted at no cash cost and are tied to the company’s common stock on a one-for-one basis. These restricted stock units vest on the first anniversary of the grant date, aligning the director’s compensation with long-term performance. After this award, Haney holds 1,188 restricted stock units directly, and may elect to receive up to 37% of them in cash instead of shares at settlement.
BIERMAN JAMES L reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare Corp director James L. Bierman reported an award of 1,188 restricted stock units tied to the company’s common stock. The units were granted at no cost and are the economic equivalent of 1,188 shares of common stock. These restricted stock units vest on the first anniversary of the grant date. Bierman may elect to receive up to 37% of the vested units in cash instead of shares, with the remainder settled in stock.
Romo Tammy reported acquisition or exercise transactions in this Form 4 filing.
Tammy Romo, a director of Tenet Healthcare, received a grant of 1,188 restricted stock units under the company’s Stock Incentive Plan. Each unit is the economic equivalent of one common share.
The units vest on the first anniversary of the grant, and she may elect to receive up to 37% of them in cash instead of shares, leaving her reported derivative holdings at 1,188 units.
Tenet Healthcare director Christopher S. Lynch received a grant of 1,188 restricted stock units tied to common stock. These 2026 May Restricted Stock Units were awarded at no exercise price and are structured as equity-based compensation.
The units vest on the first anniversary of the grant date, 27 May 2027, meaning Lynch must remain eligible through that date to receive the shares or cash. Each unit is the economic equivalent of one share of Tenet’s common stock, and Lynch may elect to receive up to 37% of the vested units in cash instead of shares.
KERREY J ROBERT reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare Corp director J. Robert Kerrey received a new equity award as part of his compensation. He was granted 1,464 restricted stock units linked to the company’s common stock, with no cash paid by him for the grant.
The units are granted under Tenet’s Stock Incentive Plan and each unit represents the economic equivalent of one common share. These restricted stock units vest on the first anniversary of the grant date, and Kerrey may elect to receive up to 37% of the vested units in cash instead of shares. Following this award, his reported derivative holdings from this grant total 1,464 units.
Fitzgerald Meghan reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare director Meghan Fitzgerald received a grant of 1,188 restricted stock units (RSUs). These 2026 May RSUs were awarded at a stated price of $0.00 per unit as part of the company’s Stock Incentive Plan and are economically equivalent to shares of common stock.
The RSUs vest on the first anniversary of the grant date, aligning compensation with future service. Following this award, Fitzgerald holds 1,188 RSUs directly. She may elect to receive up to 37% of the vested RSUs in cash instead of common shares, making this a routine compensation-related equity grant rather than an open-market trade.
Tenet Healthcare director James L. Bierman exercised 1,333 restricted stock units into common stock. On this transaction date, 1,333 units, each economically equivalent to one share of Tenet Healthcare common stock, converted into 1,333 shares at a stated price of $0.00 per share.
Following the exercise, Bierman directly holds 36,604 shares of Tenet Healthcare common stock. The derivative award labeled as 2025 May Restricted Stock Units now shows zero remaining units, indicating this specific RSU grant has been fully settled into shares.
Tenet Healthcare director Christopher S. Lynch reported a routine equity compensation event. On May 22, 2026, he exercised 1,333 2025 May Restricted Stock Units, each equivalent to one share of Tenet Healthcare common stock, receiving 1,333 shares of Common Stock at a stated price of $0.00 per share.
Following the transaction, Lynch directly held 13,405 shares of Tenet Healthcare common stock. The derivative position in the 2025 May Restricted Stock Units was reduced to zero. A footnote states that his total reported holdings reflect a decrease of 278 shares from previously filed Forms 4 to correct an error.
Tenet Healthcare Corp director Nadja West reported routine equity compensation activity. On May 22, 2026, West exercised 1,333 restricted stock units that were economically equivalent to common shares, receiving Tenet common stock at a conversion price of $0.00 per share.
In connection with this settlement, 37% of the restricted stock units were settled for cash and 63% were settled in shares of Tenet common stock. West also disposed of 493 common shares back to the issuer at $173.78 per share. After these transactions, West directly owned 27,805 shares of Tenet common stock.
Tammy Romo, a director of Tenet Healthcare, exercised 1,333 2025 May restricted stock units into 1,333 shares of common stock on May 22, 2026. A footnote explains that each unit was the economic equivalent of one share and that 37% of the units were settled for cash and 63% for shares.
On the same date, Romo disposed of 493 shares of common stock to the issuer at $173.78 per share. After these transactions, Romo directly holds 35,706 shares of Tenet Healthcare common stock.
Tenet Healthcare director Richard W. Fisher reported routine equity compensation activity. On May 22, 2026, he exercised 1,333 restricted stock units into common stock, then disposed of 493 shares back to the issuer at $173.78 per share. A footnote states that 37% of his restricted stock units were settled for cash and 63% for Tenet common shares. Following these transactions, he directly holds 9,632 shares of Tenet Healthcare common stock.
Tenet Healthcare Corp director Meghan Fitzgerald reported routine equity compensation activity involving company common stock. On May 22, 2026, she exercised 1,333 restricted stock units, receiving the same number of Tenet common shares. The filing notes each unit was economically equivalent to one THC share.
On the same date, she disposed of 493 common shares back to the issuer at $173.78 per share. After these transactions, she held 17,087 shares of Tenet Healthcare common stock directly, and the referenced 2025 May restricted stock units were fully settled.
Director Vineeta Agarwala of Tenet Healthcare Corp exercised previously granted equity awards and increased her direct holdings of common stock. She converted 1,333 restricted stock units, each equivalent to one share of Tenet common stock, into the same number of common shares. Following this transaction, she directly owns 4,446 shares of Tenet common stock. The filing shows an exercise of derivative securities with no reported open-market purchases or sales.
Tenet Healthcare Corp director Cecil D. Haney reported routine equity compensation activity involving restricted stock units and common shares. He exercised derivative securities labeled as 2025 May Restricted Stock Units into 1,333 shares of common stock, with the units economically equivalent to Tenet common stock. A portion of this award was settled in cash and the remainder in shares, as described in the footnote. The filing also shows a disposition of 493 common shares back to the issuer at $173.78 per share. After these transactions, Haney directly holds 13,853 shares of Tenet common stock.
Tenet Healthcare Corp director Richard J. Mark reported compensation-related share movements. On 2026-05-22, he exercised 1,333 restricted stock units into an equal number of common shares at an exercise price of $0.00 per share.
On the same date, he disposed of 493 common shares back to the issuer in a transaction coded "D" at $173.78/share. After these transactions, he directly held 35,121 shares of Tenet Healthcare common stock. A footnote explains that he settled 37% of his restricted stock units for cash and 63% for shares.
Tenet Healthcare director J. Robert Kerrey reported routine equity compensation activity involving company stock. He exercised 1,643 restricted stock units, which were each the economic equivalent of one share of Tenet common stock, receiving value partly in cash and partly in shares.
According to the footnote, Kerrey settled 37% of these units for cash and 63% for shares. On the same date, he also disposed of 607 common shares to the issuer in a transaction coded as a disposition to issuer. After these transactions, he directly held 22,442 shares of Tenet common stock, indicating that the activity represents a relatively small adjustment to his overall ownership position.
Tenet Healthcare director Roy Blunt reported routine equity-compensation transactions involving company common stock. He exercised 1,333 restricted stock units that were each the economic equivalent of one share of Tenet Healthcare common stock, receiving shares as part of the settlement.
In connection with this activity, he disposed of 493 shares back to the issuer at a price of $173.78 per share. After these transactions, Blunt directly owns 5,189 shares of Tenet Healthcare common stock. The filing reflects compensation-related settlements rather than open-market buying or selling.
TENET HEALTHCARE CORP executive Paola M. Arbour sold common stock in an open-market transaction. On March 11, 2026, she sold 6,500 shares of Tenet Healthcare common stock at a weighted average price of $238.43 per share, with actual sale prices ranging from $238.40 to $238.68. After this sale, she directly owned 29,291 shares of Tenet Healthcare common stock.
Tenet Healthcare’s EVP, Chief Administrative Officer and General Counsel, Thomas W. Arnst, reported selling a total of 8,000 shares of common stock in open-market transactions on March 9, 2026. He sold 4,714 shares at a weighted average price of $238.42 and 3,286 shares at a weighted average price of $239.46, in multiple trades within disclosed price ranges. Following these sales, he directly holds 12 shares of Tenet Healthcare common stock.
Tenet Healthcare CEO Saumya Sutaria reported several equity compensation events involving restricted stock units and common shares. He received a grant of 36,092 2026 February restricted stock units that convert into common stock on a one-for-one basis and vest in one-third increments over three years. Previously granted RSUs from 2023 and 2024 vested, with 22,417 and 36,384 units exercised into common stock on February 27, 2026. To cover withholding taxes tied to performance and restricted stock unit vesting, he disposed of 9,282 common shares at $237.58 and 29,919 and 124,959 shares at $239.39 through tax-withholding transactions, not open-market sales. After these movements, Sutaria directly owned 658,523 shares of Tenet Healthcare common stock.
Tenet Healthcare EVP & CFO Sun Park reported equity compensation and related tax-withholding transactions. On February 27, 2026, Park received a grant of 7,520 time-based restricted stock units, which vest in one-third increments over three years and settle in common shares upon vesting.
On the same date, 4,670 restricted stock units from a 2024 award converted into an equal number of common shares. To cover withholding taxes on vested performance share units and restricted stock units, 1,626 and 1,985 common shares were withheld at prices of $237.58 and $239.39, respectively. After these transactions, Park directly held 19,438 shares of Tenet Healthcare common stock.
Tenet Healthcare EVP and CIO Paola M. Arbour reported equity compensation activity, not open‑market trading. On February 27, 2026, 1,868 restricted stock units from a February 2024 grant and 2,799 units from a March 2023 grant converted into an equal number of common shares. To cover withholding taxes upon vesting of performance and time-based restricted stock units, 499, 1,838 and 6,810 common shares were withheld at closing prices of $237.58 and $239.39 per share. After these conversions and tax-withholding dispositions, Arbour directly held 35,791 shares of Tenet Healthcare common stock.
Tenet Healthcare executive Lisa Y. Foo, EVP and Chief Operating Officer, reported several equity-related transactions in company stock. She received a grant of 7,520 restricted stock units dated 2026 February, which convert into common shares on a one-for-one basis. She also exercised 4,670 restricted stock units from a 2024 award and 4,199 units from a 2023 award, increasing her common stock holdings. To cover tax withholding obligations tied to vesting of performance and restricted stock units, 1,838 shares, 4,289 shares, and 13,706 shares of common stock were disposed of at reference prices of $237.58 and $239.39 per share, described as shares withheld for taxes rather than open-market sales. After these transactions, she directly owned 42,053 shares of Tenet Healthcare common stock.
Tenet Healthcare principal accounting officer Scott R. Ramsey reported multiple stock transactions. On March 2, 2026, he completed open-market sales totaling 8,017 shares of common stock at weighted average prices of about $230.98, $233.21, and $233.69, leaving 5,892 shares owned directly. Earlier, on February 27, 2026, restricted stock units from 2023 and 2024 grants converted one-for-one into common shares, and several transactions labeled as tax-withholding dispositions satisfied taxes due on these vestings.
Tenet Healthcare EVP and General Counsel Thomas W. Arnst reported multiple equity transactions. On March 2, 2026, he executed an open-market sale of 24,000 shares of common stock at a weighted average price of about $234.04 per share, leaving him with 8,012 directly held shares.
On February 27, 2026, he received a grant of 7,520 time-based restricted stock units and exercised previously granted restricted stock units from 2023 and 2024, which converted into common stock on a one-for-one basis. Shares totaling 1,496, 4,409, and 14,870 were withheld to cover tax obligations upon vesting at prices based on the closing market price.
Tenet Healthcare EVP & CFO Sun Park reported the vesting and exercise of 3,800 restricted stock units into 3,800 shares of common stock on February 24, 2026, at a price of $0.00 per share. Following these conversions, Park directly holds 18,379 shares of common stock and 7,602 restricted stock units. The RSUs were granted under the 2019 Stock Incentive Plan on February 24, 2025, vesting in three equal annual installments, with the first one-third vesting on February 24, 2026.
Tenet Healthcare CEO Saumya Sutaria reported an increase in directly owned shares through the vesting of restricted stock units. On February 24, 2026, 18,242 "2025 Restricted Stock Units" were exercised or converted, consistent with their one-for-one conversion into common stock.
The transaction delivered 18,242 shares of common stock at a stated price of $0.00 per share, reflecting settlement of time-based awards rather than an open-market purchase. Following these events, Sutaria directly owned 36,486 restricted stock units and 638,923 shares of common stock, all held as direct ownership.
Footnotes explain that the RSUs were granted under the 2019 Stock Incentive Plan on February 24, 2025, vest in three equal annual installments, and are settled in common stock upon vesting. The reported transaction reflects the first one-third of that grant vesting on February 24, 2026.
Tenet Healthcare executive Paola M. Arbour, EVP and Chief Information Officer, reported the vesting and conversion of equity awards tied to her compensation. On February 24, 2026, 1,267 restricted stock units from her 2025 grant converted into an equal number of shares of Tenet common stock at no exercise price.
The restricted stock units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in three equal annual installments, with this filing covering the first one-third tranche. After these transactions, Arbour directly holds 2,534 restricted stock units and 40,271 shares of common stock, reflecting a routine employee equity vesting rather than an open-market purchase or sale.
Tenet Healthcare executive Lisa Y. Foo reported the vesting and conversion of restricted stock units into common shares. On February 24, 2026, 3,800 of her 2025 Restricted Stock Units converted into 3,800 shares of Tenet Healthcare common stock at no exercise price, reflecting an exercise or conversion of a derivative security.
These restricted stock units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in equal one-third installments on each of the first three anniversaries of the grant date. The first one-third installment vested on February 24, 2026. Following this transaction, she directly holds 53,017 shares of common stock and 7,602 restricted stock units.
TENET HEALTHCARE CORP executive Thomas W. Arnst reported equity-based compensation activity. On February 24, 2026, 3,800 of his 2025 Restricted Stock Units were exercised and converted into 3,800 shares of common stock at a stated price of $0.00 per share.
The units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in three equal annual installments; the first one-third vested on February 24, 2026. After these transactions, he directly holds 7,602 restricted stock units and 41,585 shares of common stock.
Tenet Healthcare’s Principal Accounting Officer, Ramsey R. Scott, reported acquiring shares through the vesting of restricted stock units. On February 24, 2026, 443 restricted stock units converted into 443 shares of common stock at a price of $0.00 per share. Following this derivative exercise, Scott directly owned 9,891 shares of common stock and 888 restricted stock units. The units were granted under the 2019 Stock Incentive Plan, vesting in three equal annual installments, with the first third vesting on February 24, 2026 and settled in common stock.
Tenet Healthcare director Nadja West reported a charitable stock gift. On the reported date, she transferred 1,515 shares of Tenet Healthcare common stock as a bona fide gift to a charitable donor-advised fund, with no sale proceeds received. After this donation, she directly owned 26,965 shares.
Tenet Healthcare EVP and COO Lisa Y. Foo acquired 28,339 shares of common stock through a grant of performance-based restricted stock on February 13, 2026. The award was earned when the Human Resources Committee certified achievement of performance goals for the period from January 1, 2023 to December 31, 2025.
The shares were granted at no cash cost, with a reported price of $0.0000 per share, and increased her directly held common stock to 49,217 shares after the transaction.